FOXQ1 and colorectal carcinoma: Intriguingly, we established that FOXQ1 was a transcription activator of c-MYC, while FOXQ1 was a direct target of miR-378a, indicating that miR-378a, in general, is an inhibitor of FOXQ1-cMYC cascade that is activated in CRC.